Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€21.40

€21.40

0.230%
0.05
0.230%
-
 
11:31 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Schott Pharma AG & Co. Kgaa Stock

Schott Pharma AG & Co. Kgaa gained 0.230% compared to yesterday.

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: SCHOTT Pharma delivers solid final third-quarter results
EQS-News: SCHOTT Pharma delivers solid final third-quarter results
EQS-News: SCHOTT Pharma delivers solid final third-quarter results
EQS-News: SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance
EQS-News: SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance
EQS-News: SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin